Email bookmark
Font : A-A+

Drug information on Giro (Ornidazole) from Panacea Biotec Ltd.

Giro

  Tablet  
Panacea Biotec Ltd.
Generic : Ornidazole
 56.98
500mg
10 Tablets
Dhanalakshmi Chinnuswamy
Further Checked by The Medindia Medical Review Team on February, 2, 2017
Medindia currently has information on 3080 generic drugs and 110,056 brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us (info@medindia.net) if a drug is missing from our comprehensive drug price list.

Medical Condition(s) for which Giro may be prescribed


Side effects of Giro

  Central Nervous System: Drowsiness, dizziness, headache, tremor, rigidity, poor coordination, epilepsy, tiredness, temporary loss of consciousness and fainting.

  Miscellaneous: Nausea, vomiting, taste disturbances, liver impairment, skin reactions like rash, itching and inflammation.

Dosage & When it is to be taken (Indications)

PO: Adult- The recommended dose range is 0.5gm to 1.5gm daily for 1 to 7 days.

How to use Giro?

It comes as a tablet to take by mouth as directed by your physician.

When is Giro not to be taken? (Contraindications)

Hypersensitivity.

Warnings and Precautions for Giro

Caution should be exercised in patients with history of epilepsy, multiple sclerosis, liver or kidney disease, during pregnancy and breastfeeding.

• It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.

Other Precautions for Giro

Avoid excess dosage.

Storage Conditions for Giro

Store it at room temperature, and keep away from children.



Disclaimer : Change in the rate of medication is possible and the rates shown maybe more or less than the rate displayed due to added GST and pricing changes made by the companies.
Premium Membership Benefits
Buy Medicines (Drug) at Concessional Price from India
Substitutes for Giro

View all

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.